TEORICO 3 Clasificacion de Anemias 2022

Anemia: Clinical Characteristics and Classification

In this lecture, Dr. Claudio Cardia, a biochemist and faculty member, delves into the topic of anemias. He discusses clinical characteristics, definitions, erythropoietic kinetics, and primarily focuses on the classification of anemias.

Clinical Importance of Anemia

• Anemia is a global public health issue due to its association with high morbidity and mortality rates worldwide. The World Health Organization recognizes anemia as a significant concern.

Initial Assessment for Anemia Diagnosis

• The initial assessment for diagnosing anemia involves taking a detailed medical history. This includes inquiring about dietary habits to assess nutrient intake crucial for erythropoiesis.

• Factors such as medication use and exposure to chemicals are considered during the patient's interrogation to identify potential causes of hemolytic anemias.

Importance of Family History and Physical Examination

• Family history plays a vital role in diagnosing congenital conditions like thalassemias. Neurological symptoms can also provide valuable diagnostic insights; for instance, megaloblastic anemia often presents with severe neurological disorders.

• Physical examination indicators such as pallor, splenomegaly, and specific clinical features aid in determining the type of anemia present.

Hematological Evaluation for Anemia

• Utilizing hemogram results is essential in diagnosing anemia. Parameters like mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and red cell distribution width (RDW) are crucial hematimetric values to consider.

• Morphological analysis of blood cells is pivotal for classifying different types of anemias based on variations in size, shape, and color observed under microscopy.

Anemia Classification and Causes

In this section, the speaker discusses the parameters defining anemia, emphasizing the role of hemoglobin and the complexity of anemia beyond just a decrease in red blood cells.

Anemia Parameters

• Hemoglobin is the primary parameter defining anemia, often accompanied by a decrease in red blood cells. However, anemia is not solely characterized by reduced red blood cells.

• Anemia classification involves hematimetric values like PCM, HCMS, HSM, and RW. Additionally, reticulocyte count serves as a crucial parameter for classifying anemia.

Understanding Anemia Development

• Anemia can result from imbalances between erythropoiesis (production) and erythrocytosis (destruction or loss), leading to decreased red cell mass and subsequent hemoglobin reduction.

• Evaluating anemias as dynamic states of production-loss imbalance is essential. Early recognition of this imbalance through kinetic processes can predict future anemic conditions.

Anemia Types and Hypoxia

This section delves into different types of anemias based on production defects or increased destruction/loss, highlighting how these factors contribute to hypoxia development.

Anemia Categorization

• Anemias can stem from defective production (e.g., iron deficiency) or increased destruction/loss (hemolytic anemias). Combinations of these issues often lead to hypoxia.

• Various types of hypoxia include hypoxic (lung-related), anemic (resulting from decreased RBC mass), and stasis-induced hypoxia due to conditions like heart failure.

Understanding Hypoxia and Anemia

In this section, the speaker delves into the concepts of hypoxia and anemia, discussing their mechanisms, impacts, and classifications.

Mechanisms of Hypoxia

• The speaker explains that hypoxia occurs when there is a lack of oxygen supply at the cerebral level, affecting aerobic cell respiration locally.

• Different degrees of hypoxia are highlighted: local hypoxia impacting specific areas like the brain or heart (seen in acute myocardial infarction), and systemic hypoxia affecting the entire body as seen in tumor processes.

Compensatory Responses to Hypoxia

• In cases like tumor growth with high levels of hypoxia, local compensatory responses occur. Systemic hypoxia triggers kidney responses such as erythropoietin production to counteract anemia caused by reduced oxygen levels.

• Erythropoietin production aims to compensate for anemia resulting from systemic hypoxia by increasing red blood cell production.

Cellular Responses to Hypoxia

• Activation of Hypoxia-Inducible Factor 1 Alpha leads to angiogenesis (increased capillarity), enhanced cell growth, metabolism boost (especially anaerobic metabolism), and activation of genes related to metabolism under low oxygen conditions.

• Genes activated include erythropoietin and its receptor, vascular endothelial growth factor for increased vascularization, glucose transporter proteins for enhanced glucose uptake, and enzymes involved in glycolysis.

Impact on Iron Metabolism

• Hypoxic conditions stimulate transferrin and transferrin receptor production to facilitate iron transport towards bone marrow for hemoglobin synthesis. This process involves inhibition of hydroxylation under normal oxygen levels but activation during hypoxic states.

Classification of Anemias

The discussion shifts towards classifying anemias based on cellular morphology, etiology, cellular kinetics, and frequency.

Classifying Anemias

• Anemias are classified by factors such as cellular morphology. The most common globally is iron deficiency anemia followed by thalassemias (Alpha and Beta types), chronic disease-related anemia, myelodysplastic syndromes, enzymopathies, trepanocytosis among others.

New Section

In this section, the speaker discusses the process of erythropoiesis and the formation of red blood cells.

Erythropoiesis Process

• The process starts with the formation of different cell types: hydroblast, polychromatophilic erythroblast, chromatic cylinder cell transforming into reticulocytes, and finally mature red blood cells.

• Cells originate from a common precursor cell identified as BFU-E (erythroid colony-forming unit), leading to recognizable precursors and eventually mature cells.

• Different compartments in erythropoiesis include stem cells, proliferating cells, and mature red blood cells that enter peripheral blood circulation.

New Section

This section delves into medullary aplasia and its implications on cellular differentiation in erythropoiesis.

Medullary Aplasia and Cellular Defects

• Medullary defects primarily affect the stem cell level rather than differentiated cells, leading to issues like aplastic anemia or specific lineage deficiencies.

• Global medullary insufficiency results in anemia, thrombocytopenia, and leukopenia; partial insufficiency may cause isolated erythroid aplasia.

• Cell differentiation problems can lead to various types of anemias such as megaloblastic anemia due to vitamin deficiencies or chronic conditions affecting cellular differentiation.

New Section

This part explores factors influencing red blood cell destruction through hemolysis and associated conditions.

Red Blood Cell Destruction

• Hemolysis refers to premature destruction of red blood cells due to various factors like infections, tumors, inflammation impacting cellular differentiation.

• Hemolysis can be intracorpuscular where abnormalities within the red blood cell lead to its destruction as seen in hemoglobinopathies or enzymopathies.

• Anemias may present with low or high reticulocyte counts depending on underlying causes like hemoglobinopathies or enzyme deficiencies affecting red blood cell lifespan.

New Section

Discussion on anemias related to issues at the stem cell level or during differentiation processes.

Anemia Classifications

• Stem cell-related anemias like aplastic anemia result in low reticulocyte counts due to impaired regeneration capacity of the bone marrow.

• Differentiation-related issues such as iron deficiency can also lead to low reticulocyte counts indicating ineffective erythropoiesis.

New Section

The discussion focuses on analyzing population averages based on screen data and understanding small and large population averages.

Analyzing Population Averages

• The team provides SM and LPCM values, representing small and large average populations.

• Morphological classification includes microcytic, macrocytic, and normocytic classifications based on BCM.

• Common anemias in the laboratory include iron deficiency anemia and thalassemia, both being chronic microcytic anemias.

New Section

This section delves into different types of anemias such as normocytic, macrocytic, and inflammatory chronic diseases.

Types of Anemias

• Macrocytic anemias like megaloblastic anemias can result from conditions like hemolytic anemia with reticulocytosis leading to macrocytosis.

• Normocytic anemias can be seen in chronic inflammatory diseases, myelodysplastic syndromes, and hemolytic disorders.

New Section

This part discusses further classifications of normocytic anemias based on pathophysiology.

Further Classification of Normocytic Anemias

• Normochromic hypochromic categorization is based on HCM/SHCM values where hypochromic examples include iron deficiency anemia and thalassemia.

• Chronic diseases lead to mixed or normochromic normocytic anemias depending on reticulocyte count for regenerative classification.

New Section

Understanding regenerative vs. non-regenerative stages in red blood cell production is crucial for diagnosing various types of anemia.

Regenerative vs. Non-regenerative Anemias

• Low reticulocytes indicate non-regenerative stages while high reticulocytes signify regenerative stages as seen in hemolytic anemias.

• Reticulocyte counts are essential in the algorithm for studying anemia alongside hematimetric values for comprehensive analysis.

New Section

Exploring regenerative insufficiencies such as medullary aplasia aids in understanding the causes behind certain types of anemia.

Regenerative Insufficiencies

• Medullary insufficiencies range from selective erythroblastopenia to global aplasia affecting red blood cell production significantly.

Anemia and Its Causes

In this section, the speaker delves into the causes of anemia, emphasizing the importance of identifying and treating the primary pathology to address anemia effectively.

Identifying Primary Pathology for Anemia

• Anemia can be a result of various underlying issues such as thyroid problems. Correcting these primary pathologies like hypothyroidism can lead to improvement in anemia.

• Anemia is often a consequence of an underlying primary problem. Treating this primary issue is crucial for resolving anemia effectively.

Classifying and Treating Anemia

• Proper classification of anemia based on various factors discussed helps in determining the primary disease causing it. Treating this underlying condition leads to improvement in anemic conditions.

• Addressing the root cause of anemia is essential for effective treatment. Whether it's iron deficiency, chronic blood loss, leukemia, or hypothyroidism, targeting the primary pathology is key.

Various Causes and Types of Anemias

• Chronic renal insufficiency plays a significant role in causing anemia due to its impact on erythropoietin levels and iron metabolism. Treatment with recombinant erythropoietin has revolutionized managing this type of anemia.

• The discussion extends to other types of anemias like those associated with chronic inflammatory processes, highlighting the complex interplay between iron metabolism and cytokines in these conditions.

Diverse Factors Contributing to Anemias

• A multitude of factors including chronic infections, sepsis, and malignancies can lead to anemia due to disruptions in iron metabolism and erythropoietin function.

• The etiology of chronic inflammatory process-related anemias is vast and encompasses various pathologies ranging from infectious diseases to tumors.

Metabolism and Disorders Related to Red Blood Cells

This segment focuses on metabolic processes related to red blood cells along with disorders affecting their functionality.

Metabolic Processes in Red Blood Cells

• Red blood cells lack mitochondria but are vital for glycolysis and pentose phosphate pathway. Deficiencies in enzymes like pyruvate kinase can impact energy production within red blood cells.

• Enzymes like glucose 6-phosphate dehydrogenase play crucial roles in maintaining red blood cell health by regulating ATP levels for energy production while also protecting against oxidative stress.

Hemoglobin Disorders Impacting Red Blood Cells

• Hemoglobinopathies encompass qualitative (unstable hemoglobins) and quantitative (thalassemias) abnormalities affecting hemoglobin function. Toxic agents, infections, or genetic mutations can trigger hemolysis in these conditions.

• Mechanical causes such as poorly placed cardiac prostheses or immune-mediated mechanisms like autoimmune hemolytic anemias contribute significantly to hemolytic processes affecting red blood cells.

Immunological Causes of Hemolytic Anemias

• Immune-mediated hemolytic disorders involve diverse triggers including drug reactions, transfusion mismatches, or autoimmune responses leading to conditions like autoimmune hemolytic disease or hemolytic disease of newborn infants.

Hemolytic Anemias Overview

In this section, the speaker delves into the pathophysiology and classification of hemolytic anemias, discussing factors such as intravascular and extravascular destruction of red blood cells, congenital and acquired classifications, as well as immune-mediated causes.

Pathophysiology of Hemolytic Anemias

• Hemolytic anemias can be classified as congenital or acquired, with further distinctions between intravascular and extravascular types.

• Intravascular hemolysis occurs within blood vessels, leading to characteristic parameters like increased free hemoglobin, decreased haptoglobin levels, hemoglobinuria, and the presence of hemosiderin in urine.

• Extravascular hemolysis is characterized by splenomegaly. Specific parameters help differentiate it from intravascular hemolysis.

Factors Contributing to Hemolysis

• Congenital hemolytic anemias stem from issues like membrane alterations in red blood cells due to genetic conditions affecting enzymes or structural proteins.

• Problems in red blood cell metabolism can arise from membrane alterations that lead to their destruction through processes like phagocytosis or enzymopathies affecting energy reserves.

Immune-Mediated Causes of Hemolytic Anemias

• Immune-mediated hemolytic anemias encompass conditions triggered by antibodies targeting red blood cells. These may manifest as autoimmune reactions or isoimmune responses seen in diseases like hemolytic disease of the newborn.

• Laboratory tests such as the Coombs test play a crucial role in diagnosing immune-mediated hemolytic anemias by detecting antibodies bound to red blood cell membranes.

Diagnosis and Management Strategies for Hemolytic Anemias

This segment focuses on diagnostic algorithms for identifying different types of anemia based on clinical presentations and laboratory findings. The speaker also touches upon drug-induced causes of hemolysis and emphasizes the significance of syndromes like thrombotic thrombocytopenic purpura.

Diagnostic Algorithms for Anemia

• Diagnostic algorithms for anemia involve assessing factors like low hemoglobin levels, reticulocyte counts, and conducting specific tests such as the Coombs test to differentiate between autoimmune and other forms of anemia.

• Differentiating between autoimmune causes (e.g., idiopathic autoimmune disorders) and drug-induced mechanisms (e.g., drug-protein complexes triggering immune responses leading to hemolysis).

Drug-Induced Hemolysis

• Medications can induce direct or immune-mediated hemolysis through various mechanisms impacting erythrocytes' survival. Examples include chloroquine triggering crises in glucose 6-phosphate dehydrogenase deficiency.

Syndromes Associated with Hemolysis

• Syndromes like thrombotic thrombocytopenic purpura pose significant health risks due to their impact on red blood cell abnormalities. Factors such as prosthetic heart valves, infections (e.g., malaria), toxins, etc., can contribute to these conditions.

Observation of Blood Cell Forms

In this section, the speaker discusses the importance of observing various blood cell forms under a microscope for diagnostic purposes.

Observing Blood Cell Forms

• Microscopic observation is crucial in identifying different blood cell forms.

• Different cell forms such as megalocytes, target cells, and spherocytes provide valuable diagnostic information.

• Erythroblasts must be counted manually if automated equipment does not do so; their presence can indicate certain conditions.

• An algorithm is used to study anemia types based on parameters like mean corpuscular volume (MCV) and red blood cell distribution width (RDW).

• Interpretation of MCV and RDW values helps differentiate between iron-deficiency anemia and thalassemia.

Diagnosis of Anemia

This part focuses on diagnosing anemia through analyzing various blood parameters and using algorithms.

Diagnosing Anemia

• Microcytic hypochromic anemia with high RDW suggests iron deficiency anemia but requires further tests for confirmation.

• Iron-deficiency anemia typically presents with low MCV values below 60 fl.

• Different combinations of MCV, reticulocyte count, and RDW help diagnose various types of anemia.

• High reticulocyte count indicates hemolytic anemia; normal reticulocyte levels may suggest megaloblastic or aplastic anemias.

• Classifying anemias based on parameters like reticulocyte count aids in determining appropriate diagnostic tests.

Complementary Tests for Anemia Diagnosis

The speaker discusses additional tests beyond basic blood parameters to diagnose different types of anemias accurately.

Complementary Tests

• Besides basic blood tests, complementary exams like serum ferritin levels and total iron-binding capacity (TIBC) are essential for diagnosing specific types of anemias.

• Monitoring ferritin levels serves as a marker for iron deficiency early detection despite being acute-phase reactants.

Anemia and Hematologic Studies

In this section, the speaker discusses various aspects related to anemia, including different types of anemia, diagnostic procedures like bone marrow aspiration, and specific studies used in hematologic evaluations.

Anemia Types and Diagnostic Procedures

• : Describes characteristics of anemias such as normocytic normochromic or slightly macrocytic with increased reticulocytes, LDH, and bilirubin levels.

• : Mentions bone marrow aspiration by doctors to identify conditions like aplastic anemia where there is decreased proliferative compartment.

• : Discusses the use of the osmotic fragility curve to assess red blood cell fragility.

• : Highlights tests like direct Coombs test for autoimmune hemolytic anemia and electrophoresis for hemoglobinopathies.

• : Introduces flow cytometry with markers for paroxysmal nocturnal hemoglobinuria (PNH) as a crucial study method.

Pathophysiology of Anemia

• : Explores inadequate marrow response due to chronic inflammatory processes leading to reduced erythropoietin production and altered erythroid development.

• : Details how cytokine cascades in chronic inflammatory conditions affect erythropoiesis and iron metabolism.

• : Links various pathologies like rheumatoid arthritis, lupus, renal failure to chronic process-related anemias.

Erythropoietin Levels and Treatment Considerations

• : Shares findings indicating abnormal erythropoietin levels in patients with renal insufficiency necessitating iron assessment before erythropoietin therapy initiation.

• : Emphasizes the importance of correlating erythropoietin levels with hemoglobin values for effective treatment decisions.

Monitoring Erythropoiesis and Treatment Response

• : Discusses monitoring reticulocyte counts for corrections in conditions like myelodysplastic syndromes or thalassemia major.